As of 2025-07-04, the EV/EBITDA ratio of Tandem Diabetes Care Inc (TNDM) is -18.90. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. TNDM's latest enterprise value is 1,418.48 mil USD. TNDM's TTM EBITDA according to its financial statements is -75.07 mil USD. Dividing these 2 quantities gives us the above TNDM EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 8.0x - 11.3x | 9.4x |
| Forward P/E multiples | 12.8x - 21.4x | 16.7x |
| Fair Price | (18.99) - (17.27) | (19.25) |
| Upside | -213.1% - -202.9% | -214.7% |
| Date | EV/EBITDA |
| 2025-07-02 | -19.16 |
| 2025-07-01 | -19.30 |
| 2025-06-30 | -20.55 |
| 2025-06-27 | -20.81 |
| 2025-06-26 | -20.96 |
| 2025-06-25 | -21.24 |
| 2025-06-24 | -21.91 |
| 2025-06-23 | -21.95 |
| 2025-06-20 | -21.95 |
| 2025-06-18 | -22.11 |
| 2025-06-17 | -21.82 |
| 2025-06-16 | -21.79 |
| 2025-06-13 | -22.43 |
| 2025-06-12 | -22.57 |
| 2025-06-11 | -23.13 |
| 2025-06-10 | -23.92 |
| 2025-06-09 | -21.96 |
| 2025-06-06 | -22.45 |
| 2025-06-05 | -22.34 |
| 2025-06-04 | -21.91 |
| 2025-06-03 | -22.31 |
| 2025-06-02 | -21.95 |
| 2025-05-30 | -21.59 |
| 2025-05-29 | -22.89 |
| 2025-05-28 | -22.77 |
| 2025-05-27 | -23.07 |
| 2025-05-23 | -22.39 |
| 2025-05-22 | -22.32 |
| 2025-05-21 | -23.22 |
| 2025-05-20 | -24.88 |
| 2025-05-19 | -24.18 |
| 2025-05-16 | -24.49 |
| 2025-05-15 | -24.15 |
| 2025-05-14 | -24.28 |
| 2025-05-13 | -24.53 |
| 2025-05-12 | -24.81 |
| 2025-05-09 | -24.40 |
| 2025-05-08 | -24.18 |
| 2025-05-07 | -23.76 |
| 2025-05-06 | -22.92 |
| 2025-05-05 | -22.90 |
| 2025-05-02 | -23.07 |
| 2025-05-01 | -21.74 |
| 2025-04-30 | -18.96 |
| 2025-04-29 | -18.89 |
| 2025-04-28 | -19.51 |
| 2025-04-25 | -20.03 |
| 2025-04-24 | -19.69 |
| 2025-04-23 | -18.71 |
| 2025-04-22 | -18.51 |